Supplementary Files
Keywords
outpatient care
uterine leiomyoma
regulatory document
standard operating procedure
Categories
Abstract
Introduction. Uterine leiomyoma is the most common benign tumor of the female reproductive system, affecting up to 70 % of women in the population. New regulatory documents increase the requirements for the organization of follow-up care for patients with uterine leiomyoma.
Objective is to substantiate measures aimed at optimizing follow-up care for patients with uterine leiomyoma based on an analysis of current practice and new regulatory requirements.
Methods. A retrospective descriptive study was conducted at antenatal clinics in Ekaterinburg. A total of 100 follow-up monitoring records (Form No. 030/u), outpatient medical records (Form No. 025/u), and registration logs for 2023–2024 were analyzed. Descriptive statistical methods were used, including absolute numbers, proportions, and mean ± standard deviation.
Results. Follow-up care coverage among patients with uterine leiomyoma was 72 %, while 28 % of women were not included in systematic monitoring. Violations of regulatory waiting times for scheduled ultrasound examination were recorded in 24 % of cases. The FIGO classification was absent in 85 % of outpatient records. Ferritin testing was performed in only 28 % of patients. Mild anemia was detected in 30 %. Surgical treatment was performed in 24% of women; uterus-sparing procedures accounted for 16 % of the total sample, while radical surgery was performed in 8 patients.
Conclusion. The main problems in the organization of follow-up care were incomplete medical monitoring coverage, non-compliance with the timeframes for ultrasound diagnostics, low frequency of ferritin testing, and insufficient use of the FIGO classification. To improve the effectiveness of outpatient follow-up care, the introduction of mandatory fields in medical information systems for recording the FIGO fibroid type and serum ferritin level, the implementation of an active patient recall system, and the development of a regional standard operating procedure for follow-up care of women with uterine leiomyoma are proposed.
For citation: Koval MV, Sevostyanova OY, Shakirova VV. Organization of follow-up care for patients with uterine leiomyoma: Regulatory guidelines and realities of outpatient practice. USMU Medical Bulletin. 2026;11(2):e00229. (In Russ.). DOI: https://doi.org/10.52420/usmumb.11.2.e00229. EDN: https://elibrary.ru/FALDZU.
Funding. The authors declare that there was no external funding for this study.
Conflict of interest. The authors declare no conflict of interest.
Ethics statement. The study protocol was approved by the Expert Committee of the Ural State Medical University (No. 10-01/818 dated 25 May 2026).
References
Пономаренко МС, Решетников ЕА, Пономаренко ИВ, Чурносов МИ. Этиопатогенетические механизмы развития миомы матки. Акушерство и гинекология. 2024;(1):34–41 / Ponomarenko MS, Reshetnikov EA, Ponomarenko IV, Churnosov MI. Etiopathogenetic mechanisms of uterine fibroids development. Obstetrics and Gynecology. 2024;(1):34–41. (In Russ.). DOI: https://doi.org/10.18565/aig.2023.241.
Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, et al. Comprehensive review of uterine fibroids: Developmental origin, pathogenesis, and treatment. Endocrine Reviews. 2022;43(4):678–719. DOI: https://doi.org/10.1210/endrev/bnab039.
Vannuccini S, Clemenza S, Cassioli E, Rossi E, Castellini G, Ricca V, et al. Uterine fibroids, perceived stress, and menstrual distress: A key role of heavy menstrual bleeding. Reproductive Sciences. 2023;30(5):1608–1615. DOI: https://doi.org/10.1007/s43032-022-01126-3.
Koltsova AS, Efimova OA, Pendina AA. A view on uterine leiomyoma genesis through the prism of genetic, epigenetic and cellular heterogeneity. International Journal of Molecular Sciences. 2023;24(6):5752. DOI: https://doi.org/10.3390/ijms24065752.
Обоскалова ТА, Севостьянова ОЮ, Коваль МВ, Омарбекова АТ. Особенности анамнеза женщин с миомой матки. Акушерство и гинекология. 2025;(10):143–148 / Oboskalova TA, Sevostyanova OY, Koval MV, Omarbekova AT. Features of medical history of women with uterine fibroids. Obstetrics and Gynecology. 2025;(10):143–148. (In Russ.). DOI: https://doi.org/10.18565/aig.2025.156.
Севостьянова ОЮ, Коваль МВ, Чумарная ТВ, Беломестнов СР, Севостьянова НЕ, Обоскалова ТА, и др. Анализ заболеваемости лейомиомой матки в г. Екатеринбурге. Опухоли женской репродуктивной системы. 2024;20(2):99–104 / Sevostyanova OY, Koval MV, Chumarnaya TV, Belomestnov SR, Sevostyanova NE, Oboskalova TA, et al. Analysis of uterine leiomyoma incidence in Ekaterinburg. Tumors of Female Reproductive System. 2024;20(2):99–104. (In Russ.). DOI: https://doi.org/10.17650/1994-4098-2024-16-2-99-104.
Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. International Journal of Gynecology & Obstetrics. 2018;143(3):393–408. DOI: https://doi.org/10.1002/ijgo.12666.
Савельева ГМ, Сухих ГТ, Серова ВН, Манухин ИБ, Радзинский ВЕ (ред.). Гинекология: национальное руководство. 2-е изд., перераб. И доп. Москва: ГЭОТАР-Медиа; 2017. 1008 с. / Savelieva GM, Sukhikh GT, Serova VN, Manukhin IB, Radzinsky VE (eds.). Gynecology: National guide. 2nd ed., rev. and add. Moscow: GEOTAR-Media; 2017. 1008 p. (In Russ.). EDN: https://elibrary.ru/XYDEZF.
Енькова ЕВ, Киселева ЕВ, Хоперская ОВ, Хатунцев АВ, Тюрина ИД. Аномальные маточные кровотечения: этиология и патогенез (описательный обзор). Научные результаты биомедицинских исследований. 2022;8(3):365–381 / Enkova EV, Kiseleva EV, Khoperskaya OV, Khatuntsev AV, Tyurina ID. Abnormal uterine bleeding: Etiology and pathogenesis (descriptive review). Research Results in Biomedicine. 2022;8(3):365–381. (In Russ.). DOI: https://doi.org/10.18413/2658-6533-2022-8-3-0-8.
Коваль МВ, Богданова АМ, Светлаков ГП, Ковалева ИЮ, Чащина ВИ. Миома матки гигантских размеров: клинический случай. Гинекология. 2025;27(2):153–156 / Koval MV, Bogdanova AM, Svetlakov GP, Kovaleva IY, Chashchina VI. Uterine fibroids of gigantic size: A clinical case. Gynecology. 2025;27(2):153–156. (In Russ.). DOI: https://doi.org/10.26442/20795696.2025.2.203241.
Стуклов НИ. Железодефицитная анемия в практике гинеколога. Алгоритмы диагностики, профилактики и лечения. Акушерство и гинекология. 2016;(7):99–104 / Stuklov NI. Iron-deficiency anemia in gynecological practice: Algorithms for diagnosis, prevention, and treatment. Obstetrics and Gynecology. 2016;(7):99–104. (In Russ.). DOI: https://doi.org/10.18565/aig.2016.7.99-104.
Leyland N, Leonardi M, Murji A, Singh SS, Bradley L, Li TC, et al. A call-to-action for clinicians to implement evidence-based best practices when caring for women with uterine fibroids. Reproductive Sciences. 2022;29(4):1188–1196. DOI: https://doi.org/10.1007/s43032-022-00877-3.
Centini G, Cannoni A, Ginetti A, Colombi I, Giorgi M, Schettini G, et al. Tailoring the diagnostic pathway for medical and surgical treatment of uterine fibroids: A narrative review. Diagnostics. 2024;14(18):2046. DOI: https://doi.org/10.3390/diagnostics14182046.
Ghant MS, Sengoba KS, Vogelzang R, Lawson AK, Marsh EE. An altered perception of normal: Understanding causes for treatment delay in women with symptomatic uterine fibroids. Journal of Women’s Health. 2016;25(8):846–852. DOI: https://doi.org/10.1089/jwh.2015.5531.
Тихомиров АЛ, Сарсания СИ. Лейомиома матки и ЖДА. Вариант предоперационной подготовки. Медицинский совет. 2019;(13):178–182 / Tikhomirov AL, Sarsaniya SI. Uterine leiomyoma and iron deficiency anemia. A variant of preoperative preparation. Medical Council. 2019;(13):178–182. (In Russ.). DOI: https://doi.org/10.21518/2079-701X-2019-13-178-182.
Mansour D, Hofmann A, Gemzell-Danielsson K. A review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding. Advances in Therapy. 2021;38(1):201–225. DOI: https://doi.org/10.1007/s12325-020-01564-y.
Vela D, Bernardez F, Braxs C, Calaf J, Calle E, Carpintero P, et al. Ferritin before hemoglobin: Impact of abnormal uterine bleeding on quality of life. Journal of Endometriosis and Uterine Disorders. 2025;9:100098. DOI: https://doi.org/10.1016/j.jeud.2024.100098.
Благодарева МС, Брынза НС. Удовлетворенность пациенток организацией оказания акушерско-гинекологической помощи в Свердловской области. Проблемы стандартизации в здравоохранении. 2023;(11–12):72–78 / Blagodareva MS, Brynza NS. Patients satisfaction with the provision of obstetric and gynecological care in the Sverdlovsk Region. Health Care Standardization Problems. 2023;(11–12):72–78. (In Russ.). DOI: http://doi.org/10.26347/1607-2502202311-12072-078.
Драпкина ОМ, Балан ВЕ, Баранов ИИ, Волкова СА, Громова ОА, Куняева ТА, и др. Резолюция Совета экспертов «Лечение и профилактика железодефицитных состояний на современном этапе в условиях реальной клинической практики. Место комбинированных лекарственных препаратов железа в сочетании с фолиевой кислотой при лечении железодефицитной анемии и дефицита железа». Акушерство и гинекология. 2023;(3):155–162 / Drapkina OM, Balan VE, Baranov II, Volkova SA, Gromova OA, Kunyaeva TA, et al. The resolution of the Expert Council “Prevention and treatment of iron deficiency conditions at the present stage in real clinical practice. The place of combined iron preparations in combination with folic acid in the treatment of iron deficiency anemia and iron deficiency”. Obstetrics and Gynecology. 2023;(3):155–162. (In Russ.). DOI: https://doi.org/10.18565/aig.2023.3.155-162.
Munro MG, Mast AE, Powers JM, Kouides PA, O’Brien SH, Richards T, et al. The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia. American Journal of Obstetrics and Gynecology. 2023;229(1):1–9. DOI: https://doi.org/10.1016/j.ajog.2023.01.017.
Sholzberg M, Hillis C, Crowther M, Selby R. Diagnosis and management of iron deficiency in females. CMAJ. 2025;197(24):e680–e687. DOI: https://doi.org/10.1503/cmaj.240570.
Леваков СА, Кавиладзе МГ, Гусейнова ШТ. Миома матки: требует ли нынешняя парадигма лечения модернизации? Акушерство и гинекология. 2024;(3):35–48 / Levakov SA, Kaviladze MG, Guseynova ST. Uterine fibroids: Does the current paradigm of treatment require modernization? Obstetrics and Gynecology. 2024;(3):35–48. (In Russ.). DOI: https://doi.org/10.18565/aig.2023.308.
Lakabi R, Harth S, Meinhold-Heerlein I, Olsthoorn AV, Munro MG, Murji A. Diagnosis and classification of uterine fibroids. International Journal of Gynecology & Obstetrics. 2025;171(2):566–573. DOI: https://doi.org/10.1002/ijgo.70538.
Palheta MS, Medeiros FDC, Severiano ARG. Reporting of uterine fibroids on ultrasound examinations: An illustrated report template focused on surgical planning. Radiologia Brasileira. 2023;56(2):86–94. DOI: https://doi.org/10.1590/0100-3984.2022.0048.
Коваль МВ, Севостьянова ОЮ, Обоскалова ТА, Миляева НМ, авторы; Уральский государственный медицинский университет, патентообладатель. Схема «Алгоритм практических рекомендаций для оптимизации условий оказания амбулаторной медицинской помощи пациентам с лейомиомой матки». Патент РФ № 146957. 8 апр. 2025 / Koval MV, Sevostyanova OYu, Oboskalova TA, Milyaeva NM, inventors; Ural State Medical University, assignee. [Scheme “Algorithm of practical recommendations for optimizing the conditions for providing outpatient medical care to patients with uterine leiomyoma”]. RF patent No. 146957. 8 April 2025. (In Russ.). EDN: https://elibrary.ru/SJORSQ.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Copyright © 2026 Koval M. V., Sevostyanova O. Yu., Shakirova V. V.